Source link : https://www.newshealth.biz/health-news/rise-in-glp-1-ra-and-sglt2i-prescribing-in-patients-with-t1d/
TOPLINE: Increases in prescriptions for both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors were observed in patients with type 1 diabetes (T1D) from 2010 to 2023. METHODOLOGY: GLP-1 RAs and SGLT2 inhibitors have significant benefits in cardiorenal protection and weight management; however, these medications are currently not approved for […]
Author : News Health
Publish date : 2024-10-24 13:54:44
Copyright for syndicated content belongs to the linked Source.